AnalystsTrung Huynh
Trung Huynh's Stock Forecasts

Analyst Ranking
Top 9%
#464 out of 5511 analysts
Average Return
+22.91%
Win Rate
72%34 out of 47
Risk vs Reward
Poor
Good

Trung Huynh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+167.19%$29.23$78.10
2024-02-27 -
2025-02-26
Strong Buy
Cabaletta Bio IncCABA
+129.91%$1.17$2.69
2025-04-01 -
2026-03-31
Strong Buy
Insmed IncINSM
+91.38%$75.02$143.57
2025-03-06 -
2026-03-05
Strong Buy
Eli Lilly & CoLLY
+89.52%$625.65$1,185.71
2025-08-08 -
2026-08-07
Strong Buy
Celldex Therapeutics IncCLDX
+85.32%$18.33$33.97
2025-05-09 -
2026-05-08
Strong Buy

Trung Huynh Analyst Color

Get additional color on Trung Huynh's coverage of popular stocks

Trung Huynh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Merck & Co IncMRK
8Hold$150.00+4.32%Downgrades
a month ago
Bristol Myers Squibb CoBMY
7Hold$64.00+0.42%Maintains
2 months ago
Eli Lilly & CoLLY
12Buy$1,500.00+32.03%Maintains
2 months ago
Pfizer IncPFE
9Hold$25.00-9.26%Upgrades
3 months ago
Abbvie IncABBV
2Buy$260.00-1.16%Initiates Coverage On
7 months ago
Regeneron Pharmaceuticals IncREGN
5Hold$660.00-14.74%Maintains
10 months ago
Insmed IncINSM
9Strong Buy$223.00+85.96%Maintains
a year ago
Jasper Therapeutics IncJSPR
3Strong Buy$25.00N/AMaintains
a year ago
Amgen IncAMGN
6Hold$317.00N/AMaintains
a year ago
Celldex Therapeutics IncCLDX
2Strong Buy$38.00N/AMaintains
a year ago
Cabaletta Bio IncCABA
2Strong Buy$7.00N/AMaintains
a year ago
Kyverna Therapeutics IncKYTX
1Strong Buy$13.00N/AInitiates Coverage On
2 years ago
Johnson & JohnsonJNJ
2Hold$175.00N/AMaintains
3 years ago
Grifols SaGRFS
1BuyN/AN/AUpgrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.